Ramy Abu Sukheila, MD | |
277 Pleasant St, Fall River, MA 02721-3005 | |
(508) 676-3292 | |
Not Available |
Full Name | Ramy Abu Sukheila |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 25 Years |
Location | 277 Pleasant St, Fall River, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538548706 | NPI | - | NPPES |
103055711 | Medicaid | PA |
Facility Name | Location | Facility Type |
---|---|---|
Saint Anne's Hospital | Fall river, MA | Hospital |
St Elizabeth's Medical Center | Brighton, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Prima Care Pc | 2567356017 | 186 |
News Archive
Today, Eisai Inc. announced that 16 abstracts highlighting new data analyses on FYCOMPA (perampanel) will be presented at the 67th annual American Epilepsy Society (AES) meeting, taking place in Washington, D.C. from December 6 – 10.
Kent Invicta Chamber of Commerce hosted its prestigious awards evening, where Bedfont, picked up the sought after Exporter of the year 2017 award.
The treatment of obesity still needs improvement. In the current issue of Deutsches Ärzteblatt International, Norbert Runkel and colleagues present a new, interdisciplinary S3 guideline entitled "Bariatric Surgery".
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the formation of the company's world renowned Scientific Advisory Board (SAB). The SAB was established to provide miRagen with valuable guidance in developing an extensive pipeline of microRNA-based drugs and is comprised of leaders who are internationally recognized experts in their respective fields.
› Verified 5 days ago
Entity Name | Prima Care Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265422596 PECOS PAC ID: 2567356017 Enrollment ID: O20040214000027 |
News Archive
Today, Eisai Inc. announced that 16 abstracts highlighting new data analyses on FYCOMPA (perampanel) will be presented at the 67th annual American Epilepsy Society (AES) meeting, taking place in Washington, D.C. from December 6 – 10.
Kent Invicta Chamber of Commerce hosted its prestigious awards evening, where Bedfont, picked up the sought after Exporter of the year 2017 award.
The treatment of obesity still needs improvement. In the current issue of Deutsches Ärzteblatt International, Norbert Runkel and colleagues present a new, interdisciplinary S3 guideline entitled "Bariatric Surgery".
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the formation of the company's world renowned Scientific Advisory Board (SAB). The SAB was established to provide miRagen with valuable guidance in developing an extensive pipeline of microRNA-based drugs and is comprised of leaders who are internationally recognized experts in their respective fields.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Ramy Abu Sukheila, MD 277 Pleasant St, Fall River, MA 02721-3005 Ph: (508) 676-3292 | Ramy Abu Sukheila, MD 277 Pleasant St, Fall River, MA 02721-3005 Ph: (508) 676-3292 |
News Archive
Today, Eisai Inc. announced that 16 abstracts highlighting new data analyses on FYCOMPA (perampanel) will be presented at the 67th annual American Epilepsy Society (AES) meeting, taking place in Washington, D.C. from December 6 – 10.
Kent Invicta Chamber of Commerce hosted its prestigious awards evening, where Bedfont, picked up the sought after Exporter of the year 2017 award.
The treatment of obesity still needs improvement. In the current issue of Deutsches Ärzteblatt International, Norbert Runkel and colleagues present a new, interdisciplinary S3 guideline entitled "Bariatric Surgery".
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, announced today the formation of the company's world renowned Scientific Advisory Board (SAB). The SAB was established to provide miRagen with valuable guidance in developing an extensive pipeline of microRNA-based drugs and is comprised of leaders who are internationally recognized experts in their respective fields.
› Verified 5 days ago
Dr. Thomas J. Doyle, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-973-5919 Fax: 508-973-5916 | |
Christopher John Dionisio Mangahas, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-973-5919 Fax: 508-973-5916 | |
Vitaliy Chernyy, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-973-5919 Fax: 508-973-5916 | |
James Witkowski, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-973-5919 Fax: 508-973-5916 | |
Julianne Huynh Hetzler, D.O. Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-973-5919 Fax: 508-973-5916 | |
Wojciech Sokolowski, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 363 Highland Ave, Fall River, MA 02720 Phone: 508-973-5919 Fax: 508-973-5916 |